Cheng Y, Sun F, D’Souza A, Dhakal B, Pisano M, Chhabra S, Stolley M, Hari P, Janz S. Autonomic nervous system control of multiple myeloma. Blood Rev. 2021 Mar;46:100741. doi: 10.1016/j.blre.2020.100741. Epub 2020 Aug 11. PMID: 32807576; PMCID: PMC7876165. https://www.sciencedirect.com/science/article/abs/pii/S0268960X20300916 Cited by 8 publications
Dhakal B, D’Souza A, Kleman A, Chhabra S, Mohan M, Hari P. Salvage second transplantation in relapsed multiple myeloma. Leukemia. 2021 Apr;35(4):1214-1217. doi: 10.1038/s41375-020-1005-8. Epub 2020 Aug 4. PMID: 32747684; PMCID: PMC8020391. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020391/ Cited by 10 publications
Dhakal B, Janz S. Myeloma sleeper agent in myeloid disguise. Blood. 2019 Jul 4;134(1):3-4. doi: 10.1182/blood.2019001273. PMID: 31273002. https://ashpublications.org/blood/article/134/1/3/260652/Myeloma-sleeper-agent-in-myeloid-disguise Cited by 2 publications
Dhakal B, Miller S, Rein L, Pathak LK, Gloria L, Szabo A, Giri S, Chhabra S, Hamadani M, Paner A, Padmanabhan A, Janz S, D’Souza A, Hari P. Trends in the use of therapeutic plasma exchange in multiple myeloma. J Clin Apher. 2020 Aug;35(4):307-315. doi: 10.1002/jca.21798. Epub 2020 Jun 9. PMID: 32516865. https://onlinelibrary.wiley.com/doi/10.1002/jca.21798 Cited by 2 publications
Dhakal B, Narra RK, Giri S, Szabo A, Smunt TL, Ghose S, Pathak LK, Aryal M, Hamadani M, Chhabra S, Janz S, D’Souza A, Hari PN. Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trials. Cancer. 2020 Jun 15;126(12):2791-2801. doi: 10.1002/cncr.32831. Epub 2020 Mar 10. PMID: 32154922. https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.32831 Cited by 5 publications
Dhakal B, D’Souza A, Hamadani M, Arce-Lara C, Schroeder K, Chhabra S, Shah NN, Gauger K, Keaton T, Pasquini M, Hari P. Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma. Blood Cancer J. 2019 Jul 29;9(8):56. doi: 10.1038/s41408-019-0219-3. PMID: 31358733; PMCID: PMC6663939. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663939/ Cited by 9 publications
Dong J, Garacci Z, Buradagunta CS, D’Souza A, Mohan M, Cunningham A, Janz S, Dhakal B, Thrift AP, Hari P. Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study. Blood Cancer J. 2022 Feb 24;12(2):34. doi: 10.1038/s41408-022-00633-5. PMID: 35210395; PMCID: PMC8873507. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873507/ Cited by 4 publications
Johnson AK, Lorimer EL, Szabo A, Wu R, Shah NN, D’Souza A, Chhabra S, Hamadani M, Dhakal B, Hari P, Rao S, Carlson K, Williams CL, Knight JM. Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol. Yale J Biol Med. 2022 Mar 31;95(1):45-56. PMID: 35370486; PMCID: PMC8961707. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961707/ Cited by 0 publications
Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D’Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW. Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. Blood Adv. 2020 Feb 11;4(3):467-476. doi: 10.1182/bloodadvances.2019000765. PMID: 32027744; PMCID: PMC7013267. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013267/ Cited by 20 publications
Pisano M, Cheng Y, Sun F, Dhakal B, D’Souza A, Chhabra S, Knight JM, Rao S, Zhan F, Hari P, Janz S. Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma. Front Immunol. 2021 Jun 2;12:667054. doi: 10.3389/fimmu.2021.667054. PMID: 34149703; PMCID: PMC8206561. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206561/ Cited by 0 publications
Shi Y, Sun F, Cheng Y, Holmes B, Dhakal B, Gera JF, Janz S, Lichtenstein A. Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma. Mol Cancer Ther. 2022 Apr 1;21(4):502-510. doi: 10.1158/1535-7163.MCT-21-0016. PMID: 35086951; PMCID: PMC8983490. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983490/ Cited by 0 publications
Williams A, Baruah D, Patel J, Szabo A, Chhabra S, Dhakal B, Hari P, Janz S, Stolley M, D’Souza A. Prevalence and significance of sarcopenia in multiple myeloma patients undergoing autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2021 Jan;56(1):225-231. doi: 10.1038/s41409-020-01008-9. Epub 2020 Jul 30. PMID: 32732941; PMCID: PMC7855279. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855279/ Cited by 3 publications